IHH Healthcare Berhad | Annual Report 2024 108 Governance Investor Relations Report Dynamic Social Media Engagement LinkedIn and Telegram: To enhance our communication and share timely updates, we utilise LinkedIn and Telegram. These platforms are used to disseminate key highlights, achievements, and newsworthy developments, ensuring our stakeholders stay informed about IHH Healthcare’s progress. Transparent Quarterly Performance Updates Quarterly Analyst Briefings: We conduct live-streamed quarterly analyst briefings, providing a platform for senior management to directly address analyst inquiries and provide detailed insights into the company’s performance. Accessible Quarterly Results Materials: To ensure transparency and facilitate thorough analysis, we make the following materials available on the IR section of our website: • Press releases summarising key operational and financial highlights; • Detailed quarterly financial reports; • Presentation slides; and • Past four quarterly briefing recordings, allowing investors to review past discussions. Through these, we strive to foster open dialogue, build trust, and ensure that our analysts and investors are equipped with the information necessary to make informed decisions. Analyst and Media Engagement The breadth of IHH Healthcare’s reach as a leading international healthcare network is reflected in the extensive coverage by equity research firms. As of December 31, 2024, we were followed by 22 sell-side analysts, both domestic and international. Our Investor Relations team actively fostered strong relationships with the financial community through: • Extensive Analyst Engagement: Conducted 459 meetings with buyside and sell-side analysts throughout the year, ensuring consistent and transparent communication. • Strategic Participation in Industry Events: Participated in 15 Non-Deal Roadshows (NDRs) and conferences globally, expanding our visibility and providing valuable insights to investors. Furthermore, IHH Healthcare received impactful coverage across mainstream media outlets in Malaysia, Singapore, and our other key operating markets. This media attention reinforces our market presence and contributes to broader stakeholder awareness of our strategic initiatives and performance. No. Equity Research Firms Covering IHH in 2024 1 Affin Securities Sdn Bhd 2 AmInvestment Bank Berhad 3 Bank of America 4 BIMB Securities Sdn Bhd 5 CGS International Securities Singapore Pte Ltd 6 CIMB Securities Pte Ltd 7 CLSA Limited 8 DBS Vickers Securities 9 Goldman Sachs 10 Hong Leong Investment Bank Bhd 11 J.P. Morgan Securities (Malaysia) Sdn Bhd 12 K&N Kenanga Holdings Bhd 13 Macquarie Securities Ltd 14 Maybank Kim Eng Securities 15 MIDF Amanah Investment Bank Bhd 16 Morgan Stanley 17 Nomura Securities Co Ltd/Tokyo 18 Public Investment Bank 19 RHB Research Institute Sdn Bhd 20 TA Securities Holdings Bhd 21 UBS Securities Malaysia Sdn Bhd 22 UOB Kay Hian Pte Ltd Awards IHH Healthcare’s commitment to exemplary investor relations and corporate leadership was once again recognised in 2024 through prestigious industry accolades. We were honoured to receive five awards at the FinanceAsia Asia’s Best Company Awards 2024, including: • ‘Best Managed Company’ • ‘Best CFO’ • ‘Best Investor Relations’ Furthermore, at the Asian Excellence Awards by Corporate Governance Asia, IHH won awards including: • ‘Asia’s Best CEO’ • ‘Asia’s Best CFO’ • ‘Best Investor Relations Company’ These distinguished awards serve as a testament to IHH Healthcare’s unwavering dedication to maintaining the highest standards in investor communication, corporate governance, and financial leadership. They underscore our continuous efforts to serve the best interests of our investors and all stakeholders, reinforcing our commitment to transparency, accountability and sustainable value creation. Dividend Distribution and Shareholder Returns IHH Healthcare is committed to delivering consistent and sustainable value to our shareholders. For the financial year 2024, the Board of Directors declared a total ordinary dividend of 10.0 sen per share, representing an 11% increase over the prior year. This reflects our confidence in the Group’s financial performance and future prospects. • Final Dividend: A final cash dividend of 5.5 sen per share was paid on 28 April 2025. • Interim Dividend: An interim dividend of 4.5 sen per share was paid on 30 October 2024. • Payout Ratio: The dividend payout ratio for FY2024 was approximately 40% of Profit After Tax and Minority Interests (PATMI), excluding Exceptional Items (EI), exceeding our baseline dividend policy of 30%. IHH shareholders on Bursa Malaysia received their dividends in Malaysian Ringgit (MYR); while shareholders on the SGX received their dividends in Singapore Dollars (SGD). The Board’s dividend decisions are guided by a thorough assessment of several key factors shown below, ensuring a prudent and sustainable approach: • Cash and Cash Equivalents: The Group’s available cash reserves and liquidity position. • Return on Equity and Retained Earnings: The Group’s profitability and reinvestment strategy. • Projected Capital Expenditure and Investments: Future investment plans and their impact on cash flow.
RkJQdWJsaXNoZXIy NDgzMzc=